NCT01501838

Brief Summary

The purpose of this study is to create a registry of patients with Pulmonary Hypertension who received medical care in the Hospital Italiano of Buenos Aires.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
61mo left

Started Jan 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress65%
Jan 2017Jun 2031

First Submitted

Initial submission to the registry

June 16, 2011

Completed
7 months until next milestone

First Posted

Study publicly available on registry

December 29, 2011

Completed
5 years until next milestone

Study Start

First participant enrolled

January 1, 2017

Completed
14 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2030

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2031

Last Updated

August 24, 2025

Status Verified

August 1, 2025

Enrollment Period

14 years

First QC Date

June 16, 2011

Last Update Submit

August 19, 2025

Conditions

Hypertension, Pulmonary Arterial

Outcome Measures

Primary Outcomes (2)

  • Pulmonary Hypertension prevalence

    Pulmonary Hypertension prevalence in our community.

    1 year

  • Pulmonary Hypertension incidence

    Pulmonary Hypertension incidence in our community

    1 year

Secondary Outcomes (1)

  • Mortality rate

    1 year

Eligibility Criteria

Age17 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who meet inclusion criteria and none of exclusion criteria during the study period are eligible to this study. In the population, the PAH cohort will consist of those incident cases and prevalent cases PAH WHO group 1 aged ≥18 years between January 2017 and December 2030 who attended at Hospital Italiano of Buenos Aires.

You may qualify if:

  • Diagnosed with PAH WHO group 1 (2022 ESC/ESR guidelines criteria) as the presence of a mean pulmonary artery pressure (mPAP) greater than 20 mmHg at rest with pulmonary arterial wedge pressure (PAWP) \>15 mmHg and pulmonary vascular resistance (PVR) \>2 WU, according to the 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
  • Included in the institutional registry of PAH of Hospital Italiano de Buenos Aires
  • Aged ≥18 years at the index date.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Italiano de Buenos Aires

Buenos Aires, Buenos Aires, 1181, Argentina

RECRUITING

MeSH Terms

Conditions

Pulmonary Arterial Hypertension

Condition Hierarchy (Ancestors)

Hypertension, PulmonaryLung DiseasesRespiratory Tract Diseases

Study Officials

  • Ignacio M Bluro, MD

    Hospital Italiano de Buenos Aires

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ignacio M Bluro, MD

CONTACT

+541149590200ignacio.bluro@hospitalitaliano.org.ar

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 16, 2011

First Posted

December 29, 2011

Study Start

January 1, 2017

Primary Completion (Estimated)

December 31, 2030

Study Completion (Estimated)

June 1, 2031

Last Updated

August 24, 2025

Record last verified: 2025-08

Locations

AR(1)